#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pseudoxanthoma elasticum Andersen-Tawil syndrome Non-Hodgkin's lymphoma refractory Congenital myopathy Infection in an immunocompromised host Cutaneous T-cell lymphoma refractory Small cell lung cancer limited stage Rheumatoid arthritis Neoplasm malignant Skin cancer Fibrosarcoma metastatic Erythema multiforme Desmoplastic small round cell tumour Cholangiocarcinoma Fabry's disease More trials…

    Learn about Rare Diseases

    Carcinoid syndrome – Basic Information Vascular malformation – Trials in Disease Haemophilia A with anti factor VIII Progressive supranuclear palsy Haemolytic uraemic syndrome – Life with Disease Indolent systemic mastocytosis – Treatment Castleman’s disease – Trials in Disease Focal segmental glomerulosclerosis – Life with Disease Leiomyosarcoma – Diagnostics Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Alrefimotide CLESROVIMAB Amsacrine Tiotropium Bromide Calcium Levofolinate Tioguanine Lactose Amcenestrant Belumosudil Mesilate Trastuzumab Lepidoglyphus Destructor Dexpanthenol Fenoterol Hydrobromide Etelcalcetide Morphine Sulfate Spartalizumab Tipapkinogene Sovacivec Crofelemer Idursulfase Entrectinib More therapies…

    Learn about Your Condition

    Pancreatic fistula Angiosarcoma non-metastatic Rectal adenocarcinoma Wheezing Abdominal wall pain Intracranial calcification Hairy cell leukaemia recurrent Langerhans cell sarcoma Prostatitis Escherichia coli Obstructive airways disorder B-cell lymphoma refractory Rubella Cardiac failure chronic Liposarcoma metastatic Malignant melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Crofelemer for Adults with Short Bowel Syndrome and Intestinal Failure Without Colon in Continuity

    Recruiting

    2 1
    Investigated Diseases:
    • Short-bowel syndrome
    Investigated Drugs:
    • Crofelemer
    Germany Italy

  • Study on Vemurafenib for Children with BRAF Mutation-Resistant Histiocytosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Erdheim-Chester disease
    • Langerhans cell sarcoma
    • Rosai-Dorfman syndrome
    Investigated Drugs:
    • Vemurafenib
    Poland

  • Study of Tislelizumab immunotherapy in patients with liver cancer (hepatocellular carcinoma) who have moderately impaired liver function (Child-Pugh B)

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Tislelizumab
    France

  • Study on Obinutuzumab for Adolescents with Active Lupus Nephritis and Safety in Children Aged 5 to 12

    Recruiting

    2 1 1
    Investigated Diseases:
    • Lupus nephritis
    Investigated Drugs:
    • Mycophenolate Mofetil
    • Obinutuzumab
    France Italy Poland Spain

  • Study on Emicizumab and Drug Combination for Patients with Haemophilia A and FVIII Inhibitors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Eptacog Beta (Activated)
    • Factor Viii Inhibitor Bypassing Fraction
    • Human Coagulation Factor Viii
    Bulgaria Croatia Finland Germany Norway Spain +1

  • Study on the Effects of Potassium Canrenoate and Trometamol on Blood Flow in Brain-Dead Organ Donors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Organ donor
    Investigated Drugs:
    • Potassium Canrenoate
    • Trometamol
    • Sodium Chloride
    France
Previous Page
1 … 351 352 353 354 355 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!